Abstract Background Tumor neoantigen peptide-based vaccines. systemic immunotherapies that enhance antitumor immunity by activating and expanding antigen-specific T cells. have achieved remarkable results in the treatment of a variety of solid tumors. However. https://www.roneverhart.com/Porter-Nightstand/